Seeking Alpha

richardod

richardod
Send Message
View as an RSS Feed
View richardod's Comments BY TICKER:
Latest  |  Highest rated
  • Mylan Pursues Global Generics Dominance Strategy [View article]
    Bought MYL because I wanted to work for them never got reply to CV but stocks up 50% maybe HR their thing.
    Sep 7 08:48 AM | Likes Like |Link to Comment
  • Microsoft: Okay, What Now? [View article]
    Bad day today good times hopefully ahead.
    Sep 3 05:27 PM | Likes Like |Link to Comment
  • Microsoft: Okay, What Now? [View article]
    Bret do you think the talent Nokia could bring to the future MSFT and be that hardware game charger. Agree the price paid is small -now they need to provide drivers forward maybe a breakup in the next year.
    Sep 3 09:26 AM | Likes Like |Link to Comment
  • Microsoft: Okay, What Now? [View article]
    Yes another good article questions this week should lead to increased share price and it will be interesting what other activist else joins in.
    Sep 1 02:46 PM | 1 Like Like |Link to Comment
  • 4 Reasons To Consider GE [View article]
    Yes agree as well great stock for last while but needs to move forward 15% from here asap.
    Aug 29 02:53 PM | 1 Like Like |Link to Comment
  • General Electric's Aviation Division Is Just Lifting Off [View article]
    Great read - a great long term bet really - should be moving a lot higher impressive forward orders as you point out long $GE
    Aug 12 01:09 PM | Likes Like |Link to Comment
  • Wider Than Expected Losses At Endocyte May Not Mean A Pullback [View article]
    Agree this stock should be around $25 now and double from that within the next year.
    Aug 7 05:12 AM | Likes Like |Link to Comment
  • Enbridge's Northern Gateway Pipeline: Pros And Cons With The Simon Fraser Report [View article]
    Thanks excellently put together; awaiting results today -but looks like my new buy.
    Aug 1 08:29 AM | Likes Like |Link to Comment
  • What Does Reorganization Mean For Microsoft? [View article]
    Looking to see $MSFT hit 50 by end of the year Q3 dividend increase will take this higher great parts of the business will come together or Stev will be gone but before that he will increase the Q3 Dividend maybe a special -either way a hold until then with not much downside.
    Jul 18 01:32 PM | Likes Like |Link to Comment
  • Elan (ELN +1.3%) spiked a bit just before the close after Reuters reported Allergan (AGN +1.2%) and Forest Labs (FRX +0.3%) remain interested in the company, which will seek first-round bids next week. Mylan and Endo Health are reportedly no longer interested. Allergan and Forest are said to be considering bids due to Ireland's low corporate tax rates. (previous[View news story]
    AGN has a large manufacturing plants already in Ireland over 1000 employees, FRX also has a large unit in Ireland. Plenty of highly skilled workforce now in Ireland looking for work must make it the best location in the world now.
    Jul 12 04:34 PM | Likes Like |Link to Comment
  • Why Endocyte's Small Molecule Drug Conjugates + Imaging Platform Is Undervalued [View article]
    excellent video.
    Jul 9 04:06 PM | 1 Like Like |Link to Comment
  • A Valuation Model For Endocyte's Small Molecule Drug Conjugates And Imaging Platform [View article]
    Agree excellent company - great report and has good upside -share price looks low but movements like yesterday + then- then finishes + do not make it easy to hold long $ECYT and up 100%
    Jul 9 08:04 AM | Likes Like |Link to Comment
  • Allergan (AGN -2.8%) dips on a Goldman downgrade to Neutral this morning. The firm cites a lack of near-term catalysts, saying it now sees greater upside to Forest Labs (FRX), with its potential for significant restructuring/strategic alternatives and pending new management changes later this year. [View news story]
    Allergan Inc. (NYSE: AGN) was downgraded by analysts at Goldman Sachs from a "buy" rating to a "neutral" rating. They now have a $110.00 price target on the stock. 14.3% Upside.- must be a buy after
    these losses?
    Jun 21 02:29 PM | Likes Like |Link to Comment
  • Seadrill (SDRL -2.4%) orders an additional pair of high specification jack-up drilling rigs at ~$230M each, as it looks to capitalize on the need to renew the world’s aging jack-up fleet. The latest newbuilds bring to eight the number of jack-ups SDRL has on order from China’s Dalian Shipbuilding, with deliveries due over the next three years, and will increase its jack-up fleet to 29 units. [View news story]
    Great reason to buy more and a dip as well.
    Jun 20 10:07 AM | Likes Like |Link to Comment
  • Why Endocyte's Small Molecule Drug Conjugates + Imaging Platform Is Undervalued [View article]
    Yes one way to look at it,but they need to sell the methods as well as the new treatments. Max gains here is also giving patients new treatments they and doctors will need to know about.
    Jun 18 03:41 PM | Likes Like |Link to Comment
COMMENTS STATS
67 Comments
40 Likes